Cryptolepis sanguinolenta in mice. Res J Pharmacol 4, no. 1 (2010): 9–14.
Ansah, C., et al. Toxicological evaluation of the anti-malarial herb Cryptolepis sanguinolenta in rodents. J Pharmacol Toxicol 3 (2008): 335–43.
Appiah, Alfred A. The golden roots of Cryptolepis sanguinolenta. In African natural plant products: new discoveries and challenges in chemistry and quality, ed. H. R. Juliani, J. E. Simon, and C.-T. Ho, 231–39. ACS Symposium Series 1021. American Chemical Society, 2009.
Asase, A., et al. Medicinal plants used for the treatment of malaria in Wechiau Community Hippopotamus Sanctuary in Ghana. Abstract of an oral presentation made at the Society for Economic Botany’s 48th annual meeting, June 4–7, 2007, at Lake Forest College, Chicago, Ill. http://econbot.org/_organization_/07_annual_meetings/meetings_by_year/2007/pdfs/abstracts/asase.pdf.
Bakhlet, A. O., et al. Therapeutic utility, constituents and toxicity of some medicinal plants: a review. Vet Human Toxicol 37, no. 3 (1995): 255–58.
Banerji, J., et al. A novel route to anticonvulsant imesatins and an approach to cryptolepine, the alkaloid from Cryptolepis sp. Indian J Chem 44B (2005): 426–29.
Bérangére, G., et al. Synthesis and evaluation of analogues of 10H-indol[3–2-b]-quinoline as G-quadruplex stabilizing ligands and potential inhibitors of the enzyme telomerase. Org Biomol Chem 2 (2004): 981–88.
Bierer, D. E., et al. Antihyperglycemic activities of crytolepine analogues: an ethnobotanical lead structure isolated from Cryptolepis sanguinolenta. J Med Chem 41, no. 15 (1998): 2754–64.
Bierer, D. E., et al. Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities. J Med Chem 41, no. 6 (1998): 894–901.
Bierer, D. E. Hypoglycemic agent from cryptolepis. U.S. Patent 5,917,052, filed September 28, 1994, and issued June 29, 1999.
Boakye-Yiadom, K., et al. Cryptolepine hydrochloride effect on Staphylococcus aureus. J Pharm Sci 68, no. 12 (1979): 1510–14.
Bugyei, K. A., et al. Clinical efficacy of a tea-bag formulation of Cryptolepis sanguinolenta root in the treatment of acute uncomplicated falciparum malaria. Ghana Med J 44, no. 1 (2010): 3–9.
Cimanga, K., et al. In vitro and in vivo antiplasmodial activity of cryptolepine and related alkaloids from Cryptolepis sanguinolenta. J Nat Prod 60, no. 7 (1997): 688–91.
Cimanga, K., et al. In vitro biological activities of alkaloids from Cryptolepis sanguinolenta. Planta Med 62, no. 1 (1996): 22–27.
Dankwa, Kwabena. Evaluation of antimalarial activity of four (4) Cryptolepis sanguinolenta based herbal preparations on Plasmodium berghei in mice. Thesis, Kwame Nkruma University of Science and Technology (Ghana), 2006. http://dspace.knust.edu.gh/dspace/handle/123456789/1590.
Dassonneville, L., et al. Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis. Eur J Pharmacol 409, no. 1 (2000): 9–18.
Gibbons, S., et al. Cryptolepine hydrochloride: a potent antimycobacterial alkaloid derived from Cryptolepis sanguinolenta. Phytother Res 17, no. 4 (2003): 434–36.
Grycová, Lenka. Applications of NMR to study structures of natural compounds. PhD thesis, Masaryk University, 2010. http://is.muni.cz/th/12679/prif_d/PhD_thesis_LG.pdf.
Guittat, L., et al. Interactions of cryptolepine and neocryptolepine with unusual DNA structures. Biochemie 85, no. 5 (2003): 535–47.
Hadden, C. E., et al. 11-isopropylcryptolepine: a novel alkaloid isolated from Cryptolepis sanguinolenta characterized using submicro NMR techniques. J Nat Prod 62, no. 2 (1999): 238–40.
Humenuik, R., et al. Cytotoxicity and cell cycle effects of novel indolo[2,3-b]quinoline derivatives. Oncol Res 13, no. 5 (2003): 269–77.
Iwu, Maurice M. The Associate Program on Ethnobiology, Socio-Economic Value Assessment and Community Based Conservation. Report DAMD17–99-2–9025, prepared for the U.S. Army Medical Research and Materiel Command, Fort Detrick, Md., October 2000. http://www.dtic.mil/cgi-bin/GetTRDoc?Location=U2&doc=GetTRDoc.pdf&AD=ADA406251.
Jansen, P. C. M., and Schmelzer, G. H. Cryptolepis sanguinoleta (Lindl.) Schltr. Record from Protabase database, ed. G. J. H. Grubben and O. A. Denton (PROTA: Plant Resources of Tropical Africa/Resources vegetales de l’Afrique tropicale). Wageningen, Netherlands. http://database.prota.org/search.htm (accessed November 18, 2010).
Jaromin, A., et al. Liposomal formulation of DIMIQ, potential antitumor indolo[2,3-b] quinoline agent and its cytotoxicity on hepatoma Morris 5123 cells. Drug Deliv 15, no. 1 (2008): 49–56.
Jonckers, T. H., et al. Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives. J Med Chem 45, no. 16 (2002): 3497–508.
Kaul, A., et al. Immunopotentiating properties of Cryptolepis buchanani root extract. Phytother Res 17, no. 10 (2003): 1140–44.
Laupattarakasem, P., et al. An evaluation of the activity related to inflammation of four plants used in Thailand to treat arthritis. J Ethnopharmacol 85, no. 2–3 (2003): 207–15.
Laupattarakasem, P., et al. In vitro and in vivo anti-inflammatory potential of Cryptolepis buchanani. J Ethnopharmacol 108, no. 3 (2006): 349–54.
Luo, J., et al. Cryptolepis sanguinolenta: an ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent. Diabet Med 15, no. 5 (1998): 367–74.
Luo, J., et al. Hypoglycemic agent from cryptolepis. U.S. Patent 5,629,319, filed June 6, 1995, and issued May 13, 1997.
Maurya, et al. Pharmaceutical composition comprising extract from plant Cryptolepis buchanani for tea. U.S. Patent 6,548,086, filed December 18, 2001, and issued April 15, 2003.
Mills-Robertson, F. C., et al. In vitro antimicrobial activity of Cryptolepis sanguinolenta (Periplocaceae). Afr J Pharm Pharmacol 3, no. 10 (2009): 476–80.
Mtshemla, Vathiswa. Synthesis of 2,3-diaryl-4-methoxyquinolines via palladium-catalyzed cross coupling reactions. Master’s thesis, University of South Africa, May 2008. http://uir.unisa.ac.za/bitstream/handle/10500/2275/dissertation.pdf?sequence=1.
Noamesi, B. K., et al. Studies on cryptolepine. Planta Med 48, no. 5 (1983): 48–51.
Obua, C., et al. Antimalarial activity of some plants used in traditonal medicine in Uganda. E C Afr J Pharma Sci 5, no. 2 (2002): 1.
Olajide, O. A., et al. Anti-inflammatory properties of cryptolepine. Phytother Res 23, no. 10 (2009): 1421–25.
Olajide, O. A., et al. Synthetic cryptolepine inhibits DNA binding of NF-kappaB. Bioorg Med Chem 15, no. 1 (2007): 43–49.
Oluwafemi, A. J., et al. Evaluation of cryptolepine and huperzine derivatives as lead compounds towards new agents for the treatment of human African trypanosomiasis. Nat Prod Commun 4, no. 2 (2009): 193–98.
Otsyina, Hope R. Toxicological evaluation of Cryptolepis sanguinolenta, Momordica charantia and Euphorbia hirta in rats. Thesis, Kwame Nkruma University of Science and Technology (Ghana), 2008. http://dspace.knust.edu.gh:8080/jspui/handle/123456789/885.
Oyekan, A. O., et al. Cryptolepine inhibits platelet aggregation in vitro and in vivo and stimulates fibrinolysis ex vivo. Gen Pharmacol 19, no. 2 (1988): 233–37.
Pande, M., et al. Crystalization and preliminary X-ray analysis of cryptolepain, a novel glycosylated serine protease from Cryptolepis buchanani. Acta Crystallogr Sect F Struct Biol Cryst Commun 63, part 2 (2006): 74–80.
Paulo, A., et al. Antiplasmodial activity of Cryptolepis sanguinolenta alkaloids from leaves and roots. Planta Med 66, no. 1 (2000): 30–34.
Paulo, A., et al. Chemotaxonomic analysis of the genus Cryptolepis. Biochem Syst Ecol 31, no. 2 (2003): 155–66.
Paulo, A., et al. Cryptolepis sanguinolenta activity against diarrhoeal bacteria. J Ethnopharmacol 44, no. 2 (1994): 73–77.
Paulo, A., et al. In vitro antibacterial screening of Cryptolepis sanguinolenta alkaloids. J Ethnopharmacol 44, no. 2 (1994): 127–30.
Paulo, A., et al. Steroidal alkaloids from Cryptolepis obtusa. Phytochemistry 53, no. 3 (2000): 417–22.
Prasad, P. J. N., et al. Micropropagation of Cryptolepis buchanani Roem. & Schult. Taiwania 49, no. 1 (2004): 57–65.
Rao, V. R., et al. Interactions of cryptosin with mammalian cardiac beta-adrenoceptors. Drug Chem Toxicol 13, no. 2–3 (1990): 173–94.
Rauwald, H. W., et al. Cryptolepis sanguinolenta: antimuscarinic properties of cryptolepine and the alkaloid fraction at M1, M2 and M3 receptors. Planta Med 58, no. 6 (1992): 486–88.
Sawer, I. K., et al. The effect of cryptolepine on the morphology and survival of Escherichia coli, Candida albicans and Saccharomyces cerevisiae. J Appl Bacteriol 79, no. 3 (1995): 314–21.
Sawer, I. K., et al. The killing effect of cryptolepine on Staphylococcus aureus. Lett Appl Microbiol 40, no. 1 (2005): 24–29.
Silva, O., et al. Antimicrobial activity of Guinea-Bissau traditional remedies. J Ethnopharmacol 50, no. 1 (1996): 55–59.
Simon, J. E., et al. Medicinal crops of Africa. In Issues in new crops and new uses, ed. J. Janick and A. Whipkey, 322–31. Alexandria, Va.: ASHS Press, 2007. http://hort.purdue.edu/newcrop/ncnu07/pdfs/simon322–331.pdf.
Sittiwet, C., et al. Anti-bacterial activity of